ArticleCancer discovery2022
Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLC.
Sun Min Lim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleCancer discovery2022
Sun Min Lim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.